Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy

Added 55 days ago (24.02.2021)
Authors: Stina Söderlund; Inger Persson; Mette Ilander; Joëlle Guilhot; Henrik Hjorth-Hansen; Perttu Koskenvesa; Johan Richter; Susanne Saussele; Satu Mustjoki; Ulla Olsson-Strömberg
Read article